blog

It’s clear that the clinical team for each study is tasked with creating and managing an individual study budget. The problem is one-off study purchases do not accrue the benefits of volume discounting. Of course, there are numerous and complicated financial arrangements sponsors make with service providers to create optimal rates for clinical trial support – but what about the simple construct of, “buy one shirt, get another for free?”

Topics: clinical research, clinical trials, Patient Engagement, Patient Recruitment, Most Viewed

Facebook recently held a special, invite-only breakfast for drug marketers about recruitment for clinical trials, educating them on targeting consumers and announcing their latest initiative, “clinical trial strategy”. 

Topics: Social Media, clinical trials

Part 1 in this series of blogs on the role of referring physicians in clinical research chronicled the factors that have led to study sponsors’ lack of confidence in physician referrals as an effective patient recruitment strategy. In Part 2 of this series on Research Champions referring physicians spoke for themselves through primary research conducted by BBK Worldwide. Today, we look at best practices that lead to referring physician programs that generate compelling results.

Topics: Physician Referrals, clinical research, clinical trials

Part 1 in this series of blogs on the role of referring physicians in clinical research chronicled the factors that have led to study sponsors’ lack of confidence in physician referrals as an effective patient recruitment strategy. This installment gives voice to the referring physicians themselves by sharing results of primary research conducted by BBK Worldwide.

Topics: Physician Referrals, clinical research, clinical trials

Long ago, in a land far away, principal investigators were expected to “accrue study subjects” using their network of physician colleagues. Enrolling subjects from one’s patient panel was discouraged as therapeutic misconception might impugn study results. As a result, acceptable enrollment might run from 36 to 60 months or more.

Investigators would commonly send a “Dear Doctor” letter to others within their hospital or to their personal connections. Rarely did these letters produce effective results. Over time, referring physician programs altogether lost value and credibility due to a few commonly held beliefs:

Topics: Patient Recruitment, Physician Referrals

At this stage in the evolution of mHealth, how do we make it easier for sites and patients to stay engaged with a clinical trial? In this interview, BBK Worldwide’s Erica Mercado provides her insights on mHealth user experience optimization, adaptive engagement strategies, and mHealth’s integrated future.

Topics: Patient Engagement, clinical trials, clinical research

It’s that time of the year again – we are getting ready for DIA 2017 53rd Annual Meeting, which starts June 18^th in Chicago. With over 7,000 life sciences professionals from across all disciplines expected to attend, we look forward to engaging in insightful and inspiring discussions with leading innovators from the healthcare and clinical research industries.

Topics: DIA, DIA 2017

BBK Worldwide has coupled its reputation with the singular idea that placing patient and caregiver needs as the first priority for clinical research is a win-win for all involved. For more than twenty years, BBK has promoted the company tagline, “The Patients to Find the Cure.” Having moved our collected perspectives from the days where BBK was criticized for referring to “subjects” as “patients,” the current research environment reveres “patient centricity” as the industry mantra. So, what’s next? A new concern shrouds our efforts. The notion that technological solutions are at the root of patient-centric care, in fact, may defeat the very goal the industry wishes to accomplish.

Topics: Patient Centricity, clinical research

Digital, mobile, programmatic. These terms have become buzzwords in our industry when discussing new and emerging trends in patient recruitment support. However, for me, the most interesting part of these concepts is not the way in which programming display ad buys work, or the mobile trends we are seeing with users in different age groups. When you consider that that these advertising vehicles have been in use for almost a decade, what’s most interesting to me is that the healthcare industry is just starting to adopt these as viable tactics for patient recruitment. 

Topics: advertising, Media, clinical trials

Supporting rare disease research is a big part of our work here at BBK and rare disease recruitment is an expertise that our sponsors and CRO customers have come to expect from us.

While progress has been made to improve the lives of patients with rare disorders, there is much that still needs to be done to reach patients, further research, find new treatments and improve outcomes. Our most recent eBook, “Rare Disease Research. What’s Next?” is a collection of insights from a variety of rare disease stakeholders, including Roberta Carson, Founder and President of Zaggo, Inc. – a national nonprofit devoted to helping patients and families be more engaged members of their medical teams.

Topics: Most Viewed